Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly
NCT ID: NCT02342496
Last Updated: 2018-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2015-01-31
2015-12-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low Grade Inflammation, Gut Microbiota and Barrier Function in Elderly Humans
NCT01218165
Probiotics (L. Gasseri, B. Bifidum, B. Longum) on Immune and Intestinal Health in Healthy Older Adults
NCT01662206
Probiotic Intervention With Elderly Subjects
NCT01475942
The Effect of Probiotics on Microbial Translocation and Inflammation in HIV-infected Patients
NCT02764684
The Effect of Probiotic Intervention on Intestinal Permeability
NCT03027583
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Powder consisting of maltodextrine, treated to resemble the Active product in appearance and taste.
Placebo
Powder
Active, only probiotics
Powder consisting of freezedried bacteria at 10 billions cfu/daily dose and maltodextrine, treated to resemble the Active product in appearance and taste.
Active, only probiotics
Powder
Active, blend of berries and probiotics
Powder consisting of freezedried berries , probiotics at 10 billions cfu/daily dose and maltodextrine.
Active, blend of berries and probiotics
Powder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
Powder
Active, only probiotics
Powder
Active, blend of berries and probiotics
Powder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CRP 2-10 mg/L
* Ability to fill in a study diary by him/herself
Exclusion Criteria
* Currently on corticosteroid treatment
* Presence of chronic inflammatory disease
75 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Probi AB
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lund University
Malmo, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lazou-Ahren I, Bjorklund M, Molin G, Xu J, Onning G, Elmstahl S, Jeppsson B. Probiotic-Reduced Inflammaging in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. Probiotics Antimicrob Proteins. 2025 Oct;17(5):3429-3439. doi: 10.1007/s12602-024-10310-7. Epub 2024 Jun 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014/3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.